Club drugs: review of the ‘rave’ with a note of concern for the Indian scenario.

Simple item page
dc.contributor.authorChakraborty, Kaustav
dc.contributor.authorNeogi, Rajarshi
dc.contributor.authorBasu, Debasish
dc.date.accessioned2011-12-07T03:21:16Z
dc.date.available2011-12-07T03:21:16Z
dc.date.issued2011-06
dc.description.abstract'Club drugs’ which include Ecstasy, gamma-hydroxybutyrate (GHB), ketamine, and Rohypnol (flunitrazepam) have become popular with participants in ‘raves’, because they are perceived to enhance energy, endurance, sociability and sexual arousal. These drugs vary in their pharmacologic properties, physiological and psychological effects, and potential consequences. The use of club drugs by young people has increased in the last decade, and continue to get modified and evolve, making them very difficult to monitor. Further, these drugs are not picked up by routine drugs screening procedures, thereby making these popular with the criminals. India, which is in a phase of social transition, also faces this rising menace. Despite the nature and extent of this problem, this area has been under-researched. Data from India are sparse barring a few newspaper and police reports. Keeping abreast of current trends in club drug use prepares the clinician to recognize the clinical effects of club drug use, to manage club drug related emergencies, and to generate social awareness.en_US
dc.identifier.citationChakraborty Kaustav, Neogi Rajarshi, Basu Debasish. Club drugs: review of the ‘rave’ with a note of concern for the Indian scenario. Indian Journal of Medical Research. 2011 June; 133(6): 594-604.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/135702
dc.language.isoenen_US
dc.source.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135986/en_US
dc.subjectClub drugsen_US
dc.subjectEcstasyen_US
dc.subjectgamma-hydroxybutyrateen_US
dc.subjectketamineen_US
dc.subjectrave drugsen_US
dc.subjectrohypnolen_US
dc.subject.meshAnesthetics, Dissociative --adverse effects
dc.subject.meshAnti-Anxiety Agents --adverse effects
dc.subject.meshDesigner Drugs --adverse effects
dc.subject.meshFlunitrazepam --adverse effects
dc.subject.meshHallucinogens --adverse effects
dc.subject.meshHumans
dc.subject.meshIndia
dc.subject.meshKetamine --adverse effects
dc.subject.meshN-Methyl-3,4-methylenedioxyamphetamine --adverse effects
dc.subject.meshPsychotropic Drugs --adverse effects
dc.subject.meshSocial Behavior
dc.subject.meshStreet Drugs --adverse effects
dc.subject.meshSubstance-Related Disorders
dc.titleClub drugs: review of the ‘rave’ with a note of concern for the Indian scenario.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ijmr2011v133n6p594.pdf
Size:
369.18 KB
Format:
Adobe Portable Document Format
Description:
Journal article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Indian Journal of Medical Research